COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trialsAakash Desai, Vivek Subbiah, Justin F. Gainor et al.|Nature Reviews Clinical Oncology|2021Cited by 140
Tucatinib and Trastuzumab for Previously Treated Human Epidermal Growth Factor Receptor 2–Positive Metastatic Biliary Tract Cancer (SGNTUC-019): A Phase II Basket StudyYoshiaki Nakamura, Tanios Bekaii‐Saab, Hidetoshi Hayashi et al.|Journal of Clinical Oncology|2023Cited by 100
1305 Coformulation of favezelimab and pembrolizumab as neoadjuvant therapy for resectable cutaneous squamous cell carcinoma (cSCC): Results from cohort a of the phase 2 keyform-010 studyMatteo S Carlino, Bella Nguyen, Jia Liu et al.|Unknown|2025Cited by 0